We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.22B
AUM Growth
-$1.2B
Cap. Flow
-$1.32B
Cap. Flow %
-31.23%
Top 10 Hldgs %
40.53%
Holding
893
New
143
Increased
129
Reduced
82
Closed
273
Avg Time Held Equity + Options
3.6 quarters
Top 10 Avg Time Held Equity + Options
0.7 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.7 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$211M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$189M
3
UNVR
Univar Solutions Inc.
UNVR
+$175M
4
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$143M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$137M

Top Sells

Rank Stock Value
1
STOR
STORE Capital Corporation
STOR
+$414M
2
LHCG
LHC Group LLC
LHCG
+$211M
3
ATVI
Activision Blizzard
ATVI
+$196M
4
SGFY
Signify Health, Inc.
SGFY
+$161M
5
ONEM
1Life Healthcare
ONEM
+$141M

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.3%
3 Technology 18.64%
4 Miscellaneous 15.12%
5 Industrials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AGEN icon
301
Agenus
AGEN
$339M
$1.92M 0.05%
64,370
+2,313
+4% +$97.7K
2022 Q1
4 quarters
FLYX icon
302
flyExclusive
FLYX
$72.5M
$1.92M 0.05%
188,312
– –
2021 Q3
6 quarters
OCUL icon
303
Ocular Therapeutix
OCUL
$1.68B
$1.91M 0.05%
363,286
+57,333
+19% +$272K
2022 Q1
4 quarters
IDYA icon
304
IDEAYA Biosciences
IDYA
$3.48B
$1.91M 0.05%
138,949
+23,379
+20% +$389K
2022 Q3
2 quarters
MRSN icon
305
DELISTED
Mersana Therapeutics
MRSN
$1.9M 0.05%
18,508
-808
-4% -$113K
2022 Q1
4 quarters
MRK icon
306
Merck
MRK
$358B
$1.9M 0.05%
17,864
+14,303
+402% +$1.54M
2022 Q3
2 quarters
HIW icon
307
Highwoods Properties
HIW
$3.23B
$1.9M 0.05%
+81,952
New +$2.21M
2023 Q1
0 quarters
ARYE
308
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$1.9M 0.04%
185,349
– –
2022 Q1
4 quarters
SWKS icon
309
Skyworks Solutions
SWKS
$11.5B
$1.89M 0.04%
+16,006
New +$1.77M
2023 Q1
0 quarters
IOVA icon
310
Iovance Biotherapeutics
IOVA
$6.62B
$1.88M 0.04%
308,212
+94,677
+44% +$653K
2022 Q1
4 quarters
BCRX icon
311
BioCryst Pharmaceuticals
BCRX
$2.12B
$1.88M 0.04%
225,764
-19,249
-8% -$185K
2022 Q1
4 quarters
NEWR
312
DELISTED
New Relic, Inc.
NEWR
$1.88M 0.04%
+25,000
New +$1.69M
2023 Q1
0 quarters
LITT
313
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
$1.87M 0.04%
184,322
– –
2021 Q3
6 quarters
NFYS icon
314
DELISTED
Enphys Acquisition Corp.
NFYS
$1.86M 0.04%
182,046
– –
2022 Q2
3 quarters
BKNG icon
315
Booking.com
BKNG
$119B
$1.86M 0.04%
17,500
-29,375
-63% -$2.86M
2022 Q4
1 quarter
CNDA icon
316
DELISTED
Concord Acquisition Corp II
CNDA
$1.83M 0.04%
180,304
– –
2021 Q4
5 quarters
GRTX icon
317
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$1.83M 0.04%
+713,531
New +$1.47M
2023 Q1
0 quarters
SPT icon
318
Sprout Social
SPT
$664M
$1.83M 0.04%
+30,000
New +$1.84M
2023 Q1
0 quarters
MU icon
319
Micron Technology
MU
$1.13T
$1.81M 0.04%
+30,000
New +$1.76M
2023 Q1
0 quarters
ADT icon
320
ADT
ADT
$4.78B
$1.78M 0.04%
246,182
– –
2018 Q2
19 quarters
SCYX icon
321
SCYNEXIS
SCYX
$40.3M
$1.76M 0.04%
73,209
+6,250
+9% +$83.1K
2022 Q2
3 quarters
MRTX
322
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.76M 0.04%
47,250
+1,250
+3% +$56.2K
2022 Q4
1 quarter
INCY icon
323
Incyte
INCY
$22.8B
$1.74M 0.04%
+24,100
New +$1.89M
2023 Q1
0 quarters
IWM icon
324
PUT
iShares Russell 2000 ETF
IWM
$78.5B
$1.73M 0.04%
+2,230,000
New +$411M
2023 Q1
0 quarters
VERA icon
325
Vera Therapeutics
VERA
$2.05B
$1.73M 0.04%
+223,468
New +$1.72M
2023 Q1
0 quarters
11 12
13
14 15

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 893 positions worth $4.22B, down 22% from $5.42B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $1.32B in Q1 2023, closing 273 positions and reducing 82 holdings. Its most notable exit was STORE Capital Corporation, an estimated $414M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

Against the trend, UBS O'Connor opened a new position in Oak Street Health, Inc. worth $25.3M.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited STORE Capital Corporation in Q1 2023, selling an estimated $414M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 143 new positions and closed 273 in Q1 2023.
  • UBS O'Connor's portfolio value fell 22% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.